Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2026-01-10 @ 3:19 PM
Study NCT ID:
NCT04523857
Status:
RECRUITING
Last Update Posted:
2025-04-04
First Post:
2020-08-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords: